Prof. Xianghui Du 杜向慧
Chief Physician, Professor
Department of Thoracic Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Precision radiotherapy for breast, lung, esophageal, and mediastinal tumors. Expertise includes IMRT, IGRT, VMAT, TOMO, and CyberKnife, combined with chemotherapy, endocrine, and targeted therapies.
Dr. Du has practiced clinical oncology radiotherapy since 1988, with training at Beijing Cancer Hospital and Lyon Medical Center, France. As Director of Ward 12, Department of Thoracic Radiotherapy at Zhejiang Cancer Hospital, Dr. Du specializes in comprehensive treatment of thoracic malignancies. Research includes the SPRUEMO trial and early-stage breast cancer radiotherapy techniques.
Professional roles
- Member, Radiotherapy Professional Committee, Zhejiang Medical Association
- Standing Committee Member, Breast Cancer Professional Committee, Zhejiang Anti-Cancer Association
- Member, Lung Cancer Professional Committee, Zhejiang Anti-Cancer Association
- Reviewer, Chinese Journal of Radiation Oncology
Name order: in Chinese the family name comes first (Du Xianghui). Papers usually list the name as Xianghui Du or Du X.
Selected publications
42 papers on PubMed matched by name and affiliation; 12 as first or senior author since 2016. Most recent first- or senior-author papers:
- Future Oncol, 2023 (senior author): Analysis of the risk factors of radiation pneumonitis and the predictive ability of dosiomics in non-small-cell lung cancer. PubMed 37887073
- Pathol Int, 2023 (senior author): Circ_0001955 promotes non-small cell lung cancer cell proliferation and invasion by regulating MiR-29a-3p/NKIRAS2 axis to activate the nuclear factor-κB pathway. PubMed 37477517
- Front Oncol, 2021 (senior author): Molecular Characterization and Prognostication of Large Cell Neuroendocrine Carcinoma and Large Cell Carcinoma. PubMed 35096557
- J Transl Med, 2021 (senior author): Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: from bedside to bench. PubMed 33902615
- Biomed Res Int, 2020 (senior author): lncRNA MRUL Suppressed Non-Small Cell Lung Cancer Cells Proliferation and Invasion by Targeting miR-17-5p/SRSF2 Axis. PubMed 33123591
- Jpn J Clin Oncol, 2020 (senior author): HAGLROS is overexpressed and promotes non-small cell lung cancer migration and invasion. PubMed 32484214
- J Radiat Res, 2020 (senior author): High incidence of radiation pneumonitis in lung cancer patients with chronic silicosis treated with radiotherapy. PubMed 31822893
- Radiat Oncol, 2019 (senior author): Risk factors of grade ≥ 2 radiation pneumonitis after gemcitabine induction chemotherapy for patients with non-small cell lung cancer. PubMed 31842910
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion